Literature DB >> 30727783

Familial clustering of metabolic phenotype in brothers of women with polycystic ovary syndrome.

Karthik Subramaniam1, Archana Tripathi1, Preeti Dabadghao1.   

Abstract

Polycystic ovary syndrome (PCOS) is a complex polygenic endocrine disorder. Familial clustering of phenotype has been known and it endorses the heritability of the disease. Among brothers of women with PCOS, we found significantly higher waist circumference, elevated blood pressure and insulin resistance when compared with age and BMI matched controls. Serum DHEAS level (6.2 vs. 4.5 μmol/L) was also significantly elevated among brothers. These findings in Indian ethnicity are concordant with previous studies and emphasize the need for counseling the first-degree family members of women with PCOS for lifestyle modification to reduce future risk of metabolic syndrome. We reiterate that insulin resistance (independent of obesity) and DHEAS may represent a PCOS phenotype. Funding agency - intramural grant Sanjay Gandhi Post Graduate Institute of Medical Sciences. CTRI registration number CTRI/2017/02/007891.

Entities:  

Keywords:  DHEAS; insulin resistance; metabolic syndrome; siblings

Mesh:

Substances:

Year:  2019        PMID: 30727783     DOI: 10.1080/09513590.2019.1566451

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  4 in total

Review 1.  Immunophenotypic Profiles in Polycystic Ovary Syndrome.

Authors:  Cong Hu; Bo Pang; Zhanchuan Ma; Huanfa Yi
Journal:  Mediators Inflamm       Date:  2020-03-19       Impact factor: 4.711

2.  Transgenerational Inheritance of Reproductive and Metabolic Phenotypes in PCOS Rats.

Authors:  Hao-Lin Zhang; Ming Yi; Dong Li; Rong Li; Yue Zhao; Jie Qiao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-18       Impact factor: 5.555

3.  Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of "PCOS Males".

Authors:  Katarzyna J Siemienowicz; Panagiotis Filis; Jennifer Thomas; Paul A Fowler; W Colin Duncan; Mick T Rae
Journal:  Biomedicines       Date:  2022-05-31

4.  Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia.

Authors:  Robert Krysiak; Marcin Basiak; Bogusław Okopień
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.